What’s News in Markets: Amgen’s Prognosis, Quantum Boost, iPhone Makeover
Summary
The war with Iran pushed oil above $100, driving 10-year Treasury yields near 5% and pressuring stocks, though the market rebounded after an inflation report reinforced expectations of Federal Reserve rate hikes. Healthcare suffered as Amgen and Novartis shares plunged over 13% after a failed late-stage heart disease trial raised doubts about targeting LDL cholesterol. Meanwhile, quantum computing firms rallied on $100 million federal investments, and Apple’s stock surged nearly 4% following the launch of its $1,999 foldable iPhone Duo, which analysts expect will capture significant market …
Topics discussed
Sponsor message and show introduction
Weekly market overview and inflation pressures
Rising bond yields and Fed rate expectations
Weekly stock performance and healthcare sector decline
Amgen and Novartis drug trial failures
Impact of Novartis results on Amgen stock
Quantum computing stocks rally on government investment
Government backing for strategic tech and AI loans
Quantum computing stock performance and the $1,999 price point
Apple's new foldable iPhone Duo launch and pricing
Historical performance of foldable phones and Apple stock
Apple stock rebound and supplier gains
Show outro and credits
Closing sponsor message
Listen ad-free on Castria